McLaughlin, Katie-May (2021) Analysis of publicly available datasets to produce novel findings with clinical relevance. Doctor of Philosophy (PhD) thesis, University of Kent,. (doi:10.22024/UniKent/01.02.90273) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:90273)
PDF
Language: English Restricted to Repository staff only until September 2024.
This work is licensed under a Creative Commons Attribution 4.0 International License.
|
|
Contact us about this Publication
|
![]() |
PDF (Bibliographic list of publications included in thesis)
Supplemental Material
Language: English Restricted to Repository staff only until September 2024.
This work is licensed under a Creative Commons Attribution 4.0 International License.
|
|
Contact us about this Publication
|
![]() |
Official URL: https://doi.org/10.22024/UniKent/01.02.90273 |
Abstract
Advances in high-throughput sequencing technologies have facilitated the generation of large-scale genomic and pharmacogenomic databases. Such databases represent an important source of multi-platform data and a critical resource for biomedical research. Moreover, the computational tools available to analyse such ‘big data’ have evolved substantially in recent years. Here, we have utilised various open-access data resources for our cancer and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/coronavirus disease 2019 (COVID-19)-related research. Specifically, in our cancer studies, we have correlated expression of genes differentially expressed in response to the phosphorylation status of phosphoprotein enriched in astrocytes 15 (PEA-15) in cisplatin-treated SKOV-3 ovarian cancer cell lines with survival of cisplatin-treated patients. We have also investigated the role of deoxynucleoside triphosphate triphosphohydrolase SAMHD1 in influencing drug sensitivity and cancer patient survival using data from both cell line and clinical studies. In our SARS-CoV-2/COVID-19 studies, we have used structural data to predict the impact of differentially conserved amino acid positions (DCPs) between SARS-CoV and SARS-CoV-2 on the function of SARS-CoV-2 proteins. We have also used transcriptomic and proteomic datasets of SARS-CoV-2-infected cells and patients to identify links between pathways of COVID-19 clinicopathogenesis and deregulation of genes involved in those pathways. Our computational approach demonstrates how publicly accessible data can not only be used to complement in vitro investigations, but also to generate novel findings with clinical significance.
Item Type: | Thesis (Doctor of Philosophy (PhD)) |
---|---|
Thesis advisor: | Wass, Mark N. |
Thesis advisor: | Michaelis, Martin |
DOI/Identification number: | 10.22024/UniKent/01.02.90273 |
Uncontrolled keywords: | dataset analysis |
Subjects: | Q Science |
Divisions: | Divisions > Division of Natural Sciences > Industrial Biotechnology Centre |
SWORD Depositor: | System Moodle |
Depositing User: | System Moodle |
Date Deposited: | 20 Sep 2021 10:26 UTC |
Last Modified: | 23 Sep 2021 10:34 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/90273 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):